Firestone Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-7,227
Closed -$209K 157
2024
Q3
$209K Buy
+7,227
New +$211K 0.05% 146
2023
Q3
Sell
-6,064
Closed -$217K 129
2023
Q2
$217K Buy
6,064
+1
+0% +$39 0.07% 122
2023
Q1
$247K Sell
6,063
-495
-8% -$21.4K 0.09% 97
2022
Q4
$336K Sell
6,558
-996
-13% -$47.8K 0.12% 76
2022
Q3
$331K Buy
7,554
+4
+0.1% +$194 0.13% 79
2022
Q2
$396K Buy
7,550
+504
+7% +$25.7K 0.15% 71
2022
Q1
$365K Sell
7,046
-3,441
-33% -$179K 0.12% 81
2021
Q4
$619K Sell
10,487
-296
-3% -$14.7K 0.2% 60
2021
Q3
$422K Hold
10,783
0.14% 70
2021
Q2
$422K Buy
10,783
+2
+0% +$78 0.15% 70
2021
Q1
$391K Sell
10,781
-162
-1% -$5.75K 0.14% 74
2020
Q4
$403K Buy
10,943
+6,161
+129% +$226K 0.15% 72
2020
Q3
$166K Sell
4,782
-149
-3% -$5.22K 0.07% 102
2020
Q2
$153K Hold
4,931
0.07% 100
2020
Q1
$153K Hold
4,931
0.08% 93
2019
Q4
$183K Buy
+4,931
New +$176K 0.08% 102

Other funds holding PFE

Firestone Capital Management's PFE Position: Q4 2024 in Review

Firestone Capital Management sold out of Pfizer (PFE) in Q4 2024, closing a stake of 7,227 shares — an estimated $209K sold.

Firestone Capital Management first reported a position in PFE in Q4 2019 and held it in 16 quarters. The position peaked at $619K in Q4 2021. 2,995 funds tracked by Wall St. Rank hold PFE as of Q4 2024.

  • Firestone Capital Management reported no remaining Pfizer position as of Q4 2024 after selling out during the quarter.
  • Firestone Capital Management sold 7,227 Pfizer shares in Q4 2024, an estimated $209K.
  • Firestone Capital Management first reported a position in Pfizer in Q4 2019 and held it in 16 quarters.
  • Firestone Capital Management's Pfizer position peaked at $619K in Q4 2021.
  • 2,995 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.

Based on Firestone Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.